BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2484313)

  • 1. MHC-restricted autoantigen-reactive T cell clones in multiple sclerosis.
    Rohowsky-Kochan C; Troiano R; Cook SD
    J Immunogenet; 1989 Dec; 16(6):437-44. PubMed ID: 2484313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual specific bias usage of HLA-DR antigens in the restriction of myelin basic protein-reactive T cell clones.
    Rohowsky-Kochan C; Eiman D; Cook SD
    J Neurol Sci; 1993 Jul; 117(1-2):120-9. PubMed ID: 7691992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of myelin basic protein-specific helper T cells in multiple sclerosis: generation of suppressor T cell lines.
    Zhang JW; Schreurs M; Medaer R; Raus JC
    Cell Immunol; 1992 Jan; 139(1):118-30. PubMed ID: 1370254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human myelin basic protein-specific cytolytic T lymphocyte clones are functionally restricted by HLA class II gene products.
    Weber WE; Vandermeeren MM; Raus JC; Buurman WA
    Cell Immunol; 1989 Apr; 120(1):145-53. PubMed ID: 2467752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T lymphocyte lines and clones selected against synthetic myelin basic protein 82-102 peptide from Japanese multiple sclerosis patients.
    Inobe J; Yamamura T; Kunishita T; Tabira T
    J Neuroimmunol; 1993 Jul; 46(1-2):83-90. PubMed ID: 7689597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis.
    Zang YC; Li S; Rivera VM; Hong J; Robinson RR; Breitbach WT; Killian J; Zhang JZ
    J Immunol; 2004 Apr; 172(8):5120-7. PubMed ID: 15067096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human CD8+ T cell clone regulates autologous CD4+ myelin basic protein specific T cells.
    Chou YK; Henderikx P; Jones RE; Kotzin B; Hashim GA; Offner H; Vandenbark AA
    Autoimmunity; 1992; 14(2):111-9. PubMed ID: 1284651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential peptide specificity and HLA restriction of myelin basic protein-specific T cell clones derived from MS patients.
    Zhang JW; Chou CH; Hashim G; Medaer R; Raus JC
    Cell Immunol; 1990 Aug; 129(1):189-98. PubMed ID: 1694729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encephalitogenic T cell clones specific for myelin basic protein. An unusual bias in antigen recognition.
    Zamvil SS; Nelson PA; Mitchell DJ; Knobler RL; Fritz RB; Steinman L
    J Exp Med; 1985 Dec; 162(6):2107-24. PubMed ID: 2415664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine mRNA profile of myelin basic protein reactive T-cell clones in patients with multiple sclerosis.
    Vandevyver C; Motmans K; Stinissen P; Zhang J; Raus J
    Autoimmunity; 1998; 28(2):77-89. PubMed ID: 9771978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking.
    Aharoni R; Teitelbaum D; Arnon R; Sela M
    Proc Natl Acad Sci U S A; 1999 Jan; 96(2):634-9. PubMed ID: 9892685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination.
    Zhang J; Medaer R; Stinissen P; Hafler D; Raus J
    Science; 1993 Sep; 261(5127):1451-4. PubMed ID: 7690157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelin basic protein-specific CD4+ cytolytic T-lymphocyte clones isolated from multiple sclerosis patients.
    Weber WE; Buurman WA
    Hum Immunol; 1988 Jun; 22(2):97-109. PubMed ID: 2458331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presentation of autoantigen by human T cells.
    LaSalle JM; Ota K; Hafler DA
    J Immunol; 1991 Aug; 147(3):774-80. PubMed ID: 1713605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of autologous mixed lymphocyte culture responses by myelin basic protein-reactive T cell clones.
    Rohowsky-Kochan C; Eiman D; Denny T; Oleske J; Cook SD
    J Neuroimmunol; 1994 Feb; 50(1):59-70. PubMed ID: 7507939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity of normal T-cell lines to MBP isolated from normal and multiple sclerosis white matter.
    McLaurin JA; Hafler DA; Antel JP
    J Neurol Sci; 1995 Feb; 128(2):205-11. PubMed ID: 7537795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of T-cell receptors in multiple sclerosis: clonal expansion and persistence of human T-cells specific for an immunodominant myelin basic protein peptide.
    Wucherpfennig KW; Hafler DA
    Ann N Y Acad Sci; 1995 Jul; 756():241-58. PubMed ID: 7544075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis: comparison of the human T-cell response to S100 beta and myelin basic protein reveals parallels to rat experimental autoimmune panencephalitis.
    Schmidt S; Linington C; Zipp F; Sotgiu S; de Waal Malefyt R; Wekerle H; Hohlfeld R
    Brain; 1997 Aug; 120 ( Pt 8)():1437-45. PubMed ID: 9278633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
    Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell vaccination in multiple sclerosis patients with autologous CSF-derived activated T cells: results from a pilot study.
    Van der Aa A; Hellings N; Medaer R; Gelin G; Palmers Y; Raus J; Stinissen P
    Clin Exp Immunol; 2003 Jan; 131(1):155-68. PubMed ID: 12519400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.